
LATEST NEWS
October 2023
-
All the links have been checked and are working properly.
-
Plitidepsin: The compound has been removed as it currently has active Phase 3 clinical trial. Plitidepsin is moved to Phase 2 for an active clinical trial for Coronavirus.
​
August 2023
-
All the links have been checked and were working properly.
​
June 2023
-
The new UPDATE report was discussed and will be posted for June 2023.
-
All the links have been checked and were working properly.
-
Marizomib (Salinosporamide A; NPI-0052) is now in the Bristol Myers Squibb pipeline.
​
April 2023
-
The new UPDATE report was discussed and will be posted for April 2023.
-
The following clinical trial numbers have changed:
-
Ladiratuzumab vedotin (SGN-LIV1A) a. “[5+]” to “[4+]” under US – Active Clinical Trials
​
February 2023
-
All the links have been checked and were working properly. Recent changes in the number of active clinical trials in Phase 3 are shown below.
-
Plitidepsin has a new US Active Phase 3 trial that is updated to the Phase 3 webpage.
-
Upiftamab rilsodotin (XMT-1536) has a new US Active and European Active Phase 3 trial that is updated to the Phase 3 webpage.
​
December 2022
-
All the links have been checked and were working properly. The number of clinical trials in Phase 3 is currently reflected on the website.
​
September 2022
-
During September copyright notices were posted on the top and bottom of this page.
-
Plinabulin has 5 US Active Trials.
-
XMT-1536 (upifitamab rilsodotin) has a new US Active Phase 3 trial has been added to the Phase 3 webpage.